e-learning
resources
London 2016
Monday, 05.09.2016
Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measurement of lung function deterioration in COPD by V/P SPECT
Ari E. Lindqvist (Helsinki, Finland), Marika Bajc, J. Wang, C.Z. Wang, Ari E. Lindqvist, X.Y. He
Source:
International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Session:
Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Session type:
Thematic Poster
Number:
2224
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ari E. Lindqvist (Helsinki, Finland), Marika Bajc, J. Wang, C.Z. Wang, Ari E. Lindqvist, X.Y. He. Measurement of lung function deterioration in COPD by V/P SPECT. Eur Respir J 2016; 48: Suppl. 60, 2224
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comparison between spirometry and computed tomography to evaluate dynamic hyperinflation in COPD patients
Source: International Congress 2014 – Functional imaging
Year: 2014
Scintigraphic parameters in COPD patients
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Chest CT scans obtained in multicentre clinical routine assessments are sufficient to develop a prediction function for emphysema from lung function
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Relationships between spirometry, ventilation inhomogeneity and fast and slow ventilation lung units in COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Evaluation of spirometric severity in COPD using dynamic chest X-ray examination
Source: Annual Congress 2013 –Functional imaging
Year: 2013
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Association between dynamic hyperinflation and emphysema distribution in COPD patients
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Airspace dimension test (ADT): A novel technique for diagnosis of the peripheral lung
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Volumetric capnography in distinct phenotypes of COPD patients
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
In a general population there seems to be a link between subclinical atherosclerosis and lung hyperinflation
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept